Xeplion 150 mg
Xeplion 150 mg is a medicine authorised by Swissmedic under authorisation number 70550. The authorisation holder is EurimPharm Swiss AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 23 April 2026 and the authorisation is limited until 22 April 2031. ATC code N05AX13 places the medicine in the group Psycholeptics.
| Authorisation number | 70550 |
|---|---|
| Name | Xeplion 150 mg |
| Full name | Xeplion 150 mg, Depot-Injektionssuspension in einer Fertigspritze |
| Authorisation holder | EurimPharm Swiss AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N05AX13 |
| First authorisation | 23 April 2026 |
| Authorisation validity | 22 April 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Xeplion 150 mg, Depot-Injektionssuspension in einer Fertigspritze | B | 23 April 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Fertigspritze(n) | N05AX13 | 01.05.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Xeplion 150 mg authorised in Switzerland?
Yes. Xeplion 150 mg is authorised by Swissmedic under authorisation number 70550, data as of 01 September 2026. The authorisation is limited until 22 April 2031.
Which dispensing category does Xeplion 150 mg have?
Xeplion 150 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Xeplion 150 mg?
The authorisation holder is EurimPharm Swiss AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.